Does Cabergoline Help in Decreasing Chronic Pelvic Pain Due to Endometriosis Compared to Medroxyprogesterone Acetate? A Prospective Randomized Study

Partha Mukhopadhyay, Amit Kyal, Atri Pal, Aprateem Mukhopadhyay
In: Journal of South Asian Federation of Obstetrics and Gynaecology · 2018 · vol. 10(3) , pp. 167–169 · doi:10.5005/jp-journals-10006-1582 · W2958747813
article OA: bronze CC0 ⤵ 8 in-corpus citations
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This prospective randomized study assessed the safety and efficacy of cabergoline compared to medroxyprogesterone acetate in treating chronic pelvic pain due to endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is a chronic debilitating disease which adversely affects the equality of life of the woman. The exact pathophysiology of the disease and cause of pain is not clearly understood and so confounds an attempt to select the most favourable clinical management. The study aims to assess the safety and efficacy of cabergoline with respect to medroxyprogesterone acetate in treatment of chronic pelvic pain (CPP) due to endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_pain

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (10)

Cited by (8)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK